8-K: HSPT Clarifies SPAC Redemption Process for SL Bio Merger

Horizon Space Acquisition II Corp. issued a press release clarifying the redemption process for shareholders ahead of its proposed business combination with SL BIO Ltd. and an extension meeting.

Summary

• Horizon Space Acquisition II Corp. (HSPT) clarified the redemption process for its public shareholders regarding two upcoming extraordinary general meetings.
• The Business Combination Meeting with SL BIO Ltd. is scheduled for February 12, 2026, with a redemption deadline of 5:00 p.m. Eastern Time on February 10, 2026.
• An Extension Meeting, concerning proposed amendments to HSPT's organizational documents to extend the deadline for its initial business combination, is scheduled for February 13, 2026, with a redemption election deadline of 5:00 p.m. Eastern Time on February 11, 2026.
• Shareholders who previously elected to redeem for the Business Combination Meeting and also instruct redemption for the Extension Proposals by February 11, 2026, will have their shares redeemed if either the Business Combination is consummated or the Extension Proposals are implemented.
• If the Extension Meeting is not held or proposals not implemented, shares submitted for both redemptions will automatically be redeemed upon Business Combination consummation, unless withdrawn.
• Shares only submitted for redemption in connection with the Extension Meeting will not be redeemed if the Extension Meeting is not held or proposals not implemented.
• All other details for the Business Combination Meeting, including time, location, record date (December 29, 2025), purpose, and proposals, remain unchanged.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, procedural update. It clarifies important shareholder actions but does not introduce new information regarding the underlying business combination's prospects or financial performance, thus having a moderate impact on sentiment.

Risks

• Inability to complete the proposed Business Combination.
• Inability to recognize the anticipated benefits of the proposed Business Combination, which may be affected by the amount of cash available following any redemptions by HSPT's shareholders.
• Inability of SL Bio or the combined company to identify and integrate acquisitions.
• General economic and market conditions impacting demand for the products of SL Bio or the combined company.
• Inability to meet stock exchange listing standards following the consummation of the proposed Business Combination.
• Costs related to the proposed Business Combination.
• SL Bio's or the combined company's limited operating history.
• The possibility that the proposed Business Combination does not close, including due to the failure to receive required security holder approvals, or the failure of other closing conditions.
• There is no assurance that HSPT will hold the Extension Meeting and implement the Extension Proposals.

Future Outlook

The combined company is expected to experience growth, and the cash position following the closing of the business combination is anticipated to be a key factor. However, these forward-looking statements are subject to various risks and uncertainties, including the ability to complete the business combination, integrate acquisitions, and meet stock exchange listing standards.

Management Comments

• If you previously elected to redeem your public shares in connection with the Business Combination Meeting and you want to ensure such public shares are redeemed in the event that either the Business Combination is consummated or the Extension Proposals are implemented, you must (or must direct your bank, broker or other nominee to) instruct HSPT’s transfer agent to redeem such public shares in connection with the Extension Proposals no later than 5:00 p.m. Eastern Time on February 11, 2026, the deadline to make redemption election for the Extension Meeting.
• However, there is no assurance that HSPT will hold the Extension Meeting and implement the Extension Proposals.
• There is no change to the meeting time, the redemption deadline, the location, the record date, the purpose or any of the proposals to be acted upon at the Business Combination Meeting.

Industry Context

StockSavvy.ai notes that this filing is typical for a Special Purpose Acquisition Company (SPAC) nearing its business combination deadline or seeking an extension. The detailed clarification of the redemption process is crucial for investor decision-making, especially given the high redemption rates often seen in SPAC transactions, which can significantly impact the cash available to the de-SPACed entity. The dual meeting structure for both the merger and an extension highlights the common challenges SPACs face in completing transactions within their initial timeframe.

Stakeholder Impact

• Shareholders: Directly impacted by the redemption process clarification, requiring specific actions to ensure their redemption elections are processed correctly across two potential meetings. Voting decisions for the Business Combination and Extension Proposals are critical.

Next Steps

• Shareholders to instruct transfer agent for redemption in connection with Extension Proposals by 5:00 p.m. Eastern Time on February 11, 2026.
• Business Combination Meeting to be held on February 12, 2026, at 9:00 a.m. Eastern Time.
• Extension Meeting to be held on February 13, 2026.
• Shareholders encouraged to vote as soon as possible if they have not yet done so.

Key Dates

Recommendation

The filing provides crucial procedural clarity for shareholders regarding redemption options ahead of a significant business combination and potential extension. While not directly impacting the fundamental value of the underlying target, the redemption rate can significantly affect the cash available to the combined entity, which is a material factor for the success of the de-SPAC transaction. Investors should hold to monitor the outcome of the shareholder votes and redemption levels, as these will dictate the capital structure and viability of the combined company.

Keywords

SPAC, Business Combination, Redemption Process, Shareholder Meeting, Proxy Solicitation, SL BIO Ltd., Horizon Space Acquisition II Corp., Extension Proposals, Merger, De-SPAC